Double-blind, randomized, parallel design study comparing effectiveness of losartan vs. hydrochlorothiazide in reversing or preventing the progression of the remodeling of resistance arteries in pre-hypertensive pre-diabetic subjects
Phase of Trial: Phase I
Latest Information Update: 22 May 2015
At a glance
- Drugs Losartan (Primary) ; Hydrochlorothiazide
- Indications Hypertension
- Focus Pharmacodynamics
- 22 May 2015 Last checked against the ClinicalTrials.gov record.
- 06 Oct 2009 Planned end date (1 Dec 2009) added as reported by ClinicalTrials.gov.
- 06 Oct 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.